References
- Nelson LM, Covington SN, Rebar RW. An update: spontaneous premature ovarian failure is not an early menopause. Fertil Steril 2005;83:1327–32
- Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update 2005;11:391–410
- Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360:606–14
- Conway GS. Premature ovarian failure. Br Med Bull 2000;56:643–9
- Santoro N, Pal L. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413–23
- Davies MC, Cartwright B. What is the best management strategy for a 20-year-old woman with premature ovarian failure? Clin Endocrinol (Oxf) 2012;77:182–6
- Bakhsh H, Dei M, Bucciantini S, et al. Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density. Gynecol Endocrinol 2015;31:65–9
- Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015;7:1–9
- Maclaran K, Panay N. Current concepts in premature ovarian insufficiency. Womens Health (Lond) 2015;11:169–82
- Crofton PM, Evans N, Bath LE, et al. Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover. Clin Endocrinol (Oxf) 2010;73:707–14
- Sassarini J, Lumsden MA, Critchley HO. Sex hormone replacement in ovarian failure – new treatment concepts. Best Pract Res Clin Endocrinol Metab 2015;29:105–14
- Papagianni V, Deligeoroglou E, Makrakis E, et al. Response to hormonal treatment of young females with primary or very premature ovarian failure. Gynecol Endocrinol 2011;27:291–9
- Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health 2014;6:235–43
- Biswas D, Dutta D, Maisnam I, et al. Occurrence of osteoporosis & factors determining bone mineral loss in young adults with Graves' disease. Indian J Med Res 2015;141:322–9
- Hwang J, Lee EK, Ahn JK, et al. Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis. Osteoporos Int 2016. [Epub ahead of print]. doi:10.1007/s00198-016-3703-7
- Goldberg S, Glogauer J, Grynpas MD, Glogauer M. Deletion of filamin A in monocytes protects cortical and trabecular bone from post-menopausal changes in bone microarchitecture. Calcif Tissue Int 2015;97:113–24
- Popat VB, Calis KA, Vanderhoof VH, et al. Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab 2009;94:2277–83
- Benetti-Pinto CL, Ferreira VB, Yela DA. Long-term follow-up of bone density in women with primary ovarian insufficiency. Menopause 2015;22:946–9
- Nakamura T, Imai Y, Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 2007;130:811
- Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010;31:266
- Lee KC, Jessop H, Suswillo R, et al. The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J Endocrinol 2004;182:193–201
- Lee K, Jessop H, Suswillo R, et al. Endocrinology: bone adaptation requires oestrogen receptor-alpha. Nature 2003;424:389
- Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. JAMA 2003;290:1042–8
- Modder UI, Riggs BL, Spelsberg TC, et al. Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur J Endocrinol 2004;151:503–10
- Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. The ESHRE Guideline Group on POI. Hum Reprod 2016; 31:926–37
- Vujovic S, Brincat M, Erel T, et al. EMAS position statement: Managing women with premature ovarian failure. Maturitas 2010;67:91–3